# The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study

> **NCT06117046** · PHASE4 · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 234 (actual)

## Conditions studied

- Myocardial Injury
- ICU

## Interventions

- **DRUG:** Cardiopeptidin
- **DRUG:** 50 ml of normal saline intravenous infusion

## Key facts

- **NCT ID:** NCT06117046
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2023-11-25
- **Final completion:** 2023-11-25
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06117046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06117046, "The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06117046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*